{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:02:29Z","timestamp":1764021749028,"version":"3.45.0"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary:<\/jats:title>\n                    <jats:p>Mutations in splicing factors are commonly observed in chronic lymphocytic leukemia (CLL); however, other mechanisms can also contribute to the dysregulation of alternative splicing. One example is the overexpression of the m6A RNA methyltransferase METTL3, that by depositing the epitranscriptomic mark in spliceosome transcripts leads to aberrant splicing, but at the same time creates vulnerability to METTL3 inhibitors.<\/jats:p>\n                    <jats:p>See related article by Wu et al., p. 228 (8) .<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-23-0035","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T14:45:48Z","timestamp":1681742748000},"page":"176-179","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global Shift in Alternative Splicing and Therapeutic Susceptibilities in Leukemia Driven by METTL3 Overexpression"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-4128","authenticated-orcid":false,"given":"Maxime","family":"Janin","sequence":"first","affiliation":[{"name":"1Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain."},{"name":"2Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-6093","authenticated-orcid":false,"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[{"name":"1Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain."},{"name":"2Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain."},{"name":"3Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain."},{"name":"4Institucio Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2025112416564737800_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.2019004260","article-title":"Splicing factor mutations in hematologic malignancies","volume":"138","author":"Chen","year":"2021","journal-title":"Blood"},{"key":"2025112416564737800_bib2","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1038\/s41388-019-0936-x","article-title":"Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer","volume":"38","author":"Piqu\u00e9","year":"2019","journal-title":"Oncogene"},{"key":"2025112416564737800_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2643-3249.BCD-20-0032","article-title":"Epitranscriptomics in hematopoiesis and hematologic malignancies","volume":"1","author":"Rossell\u00f3-Tortella","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"2025112416564737800_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"2025112416564737800_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/biom13020243","article-title":"Critical roles of METTL3 in translation regulation of cancer","volume":"13","author":"Meng","year":"2023","journal-title":"Biomolecules"},{"key":"2025112416564737800_bib6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"2025112416564737800_bib7","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41375-022-01621-1","article-title":"Remodeling of the m6A RNA landscape in the conversion of acute lymphoblastic leukemia cells to macrophages","volume":"36","author":"Bueno-Costa","year":"2022","journal-title":"Leukemia"},{"key":"2025112416564737800_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1158\/2643-3230.BCD-22-0156","article-title":"METTL3-mediated m6A modification controls splicing factor abundance and contributes to aggressive CLL","volume":"4","author":"Wu","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"2025112416564737800_bib9","doi-asserted-by":"crossref","first-page":"e121438","DOI":"10.1172\/jci.insight.121438","article-title":"Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies","volume":"3","author":"Ten Hacken","year":"2018","journal-title":"JCI Insight"},{"key":"2025112416564737800_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41388-023-02602-z","article-title":"METTL3 regulates breast cancer-associated alternative splicing switches","volume":"42","author":"Achour","year":"2023","journal-title":"Oncogene"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-23-0035\/3323707\/bcd-23-0035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/4\/3\/176\/3327841\/176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/4\/3\/176\/3327841\/176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:56:53Z","timestamp":1764021413000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/4\/3\/176\/726216\/Global-Shift-in-Alternative-Splicing-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4,17]]},"published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-23-0035","relation":{},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"type":"print","value":"2643-3230"},{"type":"electronic","value":"2643-3249"}],"subject":[],"published":{"date-parts":[[2023,4,17]]}}}